Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ono Pharmaceutical
Biotech
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
LigaChem’s ADC is designed to deliver a therapeutic payload to cells that express L1CAM.
Nick Paul Taylor
Oct 10, 2024 9:40am
Shattuck axes CD47 program, cuts 40% of staff over weak data
Oct 1, 2024 8:22am
Cue lays off 25%, prioritizing preclinical autoimmune assets
Jul 26, 2024 4:29am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
Ono taps Shattuck for $227M bifunctional fusion protein deal
Feb 13, 2024 8:29am
Japan's Ono signs up for KSQ's preclinical cancer programs
Jan 25, 2023 9:55am